Hypoxic preconditioning exerts neuroprotective effects by the regulation of CDK2/HIF-1α/mTOR

  • LI Xiaoting ,
  • SUN Jiajun ,
  • LYU Xuehao ,
  • ZHU Wei ,
  • MA Ning ,
  • JIA Xiao'e
Expand
  • 1. School of Basic Medicine and Forensic Medicine, Baotou Medical College, Baotou 014040, China;
    2. Institute of Neuroscience, Baotou Medical College;
    3. Inner Mongolia Key Laboratory of Hypoxic Translational Medicine, Baotou Medical College;
    4. School of Pharmacy, Baotou Medical College;
    5. Baotou Medical College Library, Baotou Medical College

Received date: 2025-10-13

  Online published: 2026-07-16

Abstract

Objective: To explore the molecular mechanism of the neuroprotective effect of hypoxic preconditioning at the cellular level, and to provide experimental basis and target strategy for the prevention and treatment of hypoxic/ischemic diseases. Methods: The data of stroke, remote ischemic preconditioning (RIPC), hypoxic preconditioning (HPC), and oxygen-glucose deprivation/reoxygenation (OGD/R) injury models were collected. Network pharmacology was used to analyze the intersection of potential targets in related databases by Kyoto Encyclopedia of Genes and Genomes (KEGG). It was found that cyclin-dependent kinase 2 (CDK2) may be a potential target for neuroprotection of hypoxia/ischemic preconditioning. In SH-SY5Y cells, CDK2 gene was overexpressed and knocked down by transfection of CDK2 overexpression plasmid and CDK2-siRNA. Cell apoptosis and viability were detected by flow cytometry and CCK8 method to evaluate the neuroprotective effect. Western Blotting was used to verify the effects of overexpression/knockdown of CDK2 on mammalian target of rapamycin (mTOR) and hypoxia inducible factor-1α (HIF-1α) proteins. Results: In the OGD/R injury model of SH-SY5Y cells, compared with the OGD/R group, the apoptosis of HPC+OGD group was decreased (P=0.033 9), and the cell viability was increased (P=0.001 6). After knocking down CDK2, compared with the control group, the apoptosis of CDK2 knockdown group was decreased (P=0.007 3), and the cell viability was increased (P=0.002 1). After overexpression of CDK2, compared with the control group, the apoptosis of CDK2 overexpression group increased (P=0.008 8), and the cell viability decreased (P<0.000 1). Knockdown of CDK2 gene up-regulated the expression of p-mTOR and HIF-1α (P=0.0003, P=0.008 3). Overexpression of CDK2 down-regulated the expression of p-mTOR and HIF-1α (P=0.036 1, P=0.006 9). Conclusion: Hypoxic preconditioning can exert neuroprotective effects, which may be achieved by regulating the CDK2/mTOR/HIF-1α pathway.

Cite this article

LI Xiaoting , SUN Jiajun , LYU Xuehao , ZHU Wei , MA Ning , JIA Xiao'e . Hypoxic preconditioning exerts neuroprotective effects by the regulation of CDK2/HIF-1α/mTOR[J]. Journal of Baotou Medical College, 2026 , 42(5) : 12 -18 . DOI: 10.16833/j.cnki.jbmc.2026.05.003

References

[1] 张敌, 王彦华, 陈昺伃. 脑卒中半身不遂中医病机探析[J]. 陕西中医, 2024, 45(7): 947-950.
[2] Yang TS, Wang QY, Qu YY, et al. Erratum to punicalin alleviates OGD/R-triggered cell injury via TGF-β-mediated oxidative stress and cell cycle in neuroblastoma cells SH-SY5Y[J]. Evid Based Complement Alternat Med, 2021, 2021: 9840240.
[3] Yuan ZL, Mo YZ, Li DL, et al. Inhibition of ERK downregulates autophagy via mitigating mitochondrial fragmentation to protect SH-SY5Y cells from OGD/R injury[J]. Cell Commun Signal, 2023, 21(1): 204.
[4] Zeng X, Zhang YD, Ma RY, et al. Activated Drp1 regulates p62-mediated autophagic flux and aggravates inflammation in cerebral ischemia-reperfusion via the ROS-RIP1/RIP3-exosome axis[J]. Mil Med Res, 2022, 9(1): 25.
[5] Xiao L, Dai ZW, Tang WJ, et al. Astragaloside IV alleviates cerebral ischemia-reperfusion injury through NLRP3 inflammasome-mediated pyroptosis inhibition via activating Nrf2[J]. Oxid Med Cell Longev, 2021, 2021: 9925561.
[6] Hu ZZ, Yuan Y, Zhang XL, et al. Human umbilical cord mesenchymal stem cell-derived exosomes attenuate oxygen-glucose deprivation/reperfusion-induced microglial pyroptosis by promoting FOXO3a-dependent mitophagy[J]. Oxid Med Cell Longev, 2021, 2021: 6219715.
[7] Lee KE, Kim J, Park KH, et al. Remote ischemic pre-conditioning (RIPC)[J]. Methods Mol Biol, 2023, 2597: 11-18.
[8] 谢凯. 远隔缺血预适应治疗对急性缺血性脑卒中脑血管狭窄患者神经功能及BDNF、cAMP水平的影响[J]. 反射疗法与康复医学, 2024, 5(10): 124-126.
[9] Chen QH, Chen K, Guo GJ, et al. A critical role of CDKN3 in Bcr-Abl-mediated tumorigenesis[J]. PLoS One, 2014, 9(10): e111611.
[10] 李莘, 郭晓兰, 郭金, 等. 碳酸锂对小鼠胚胎神经发育细胞周期关键基因的影响[J]. 中国生育健康杂志, 2025, 36(1): 36-43, 50.
[11] 李雪华, 孙继红, 孙建国. 细胞周期蛋白依赖性激酶家族的研究进展[J]. 药学进展, 2025, 49(1): 60-68.
[12] 陈昌贵, 易春峰, 余志华, 等. 吲哚-3-甲醇通过抑制mTOR/HIF-1α信号通路减弱低氧诱导的肺动脉平滑肌细胞增殖[J]. 中南药学, 2024, 22(9): 2300-2306.
[13] Li HS, Zhou YN, Li L, et al. HIF-1α protects against oxidative stress by directly targeting mitochondria[J]. Redox Biol, 2019, 25: 101109.
[14] Rashid M, Zadeh LR, Baradaran B, et al. Up-down regulation of HIF-1α in cancer progression[J]. Gene, 2021, 798: 145796.
[15] Semenza GL. Targeting HIF-1 for cancer therapy[J]. Nat Rev Cancer, 2003, 3(10):721-732.
[16] 毕胜, 盛宝英, 韩凤, 等. 缺氧诱导因子1α参与大脑中动脉闭塞模型大鼠的脑损伤与脑保护[J]. 中国组织工程研究, 2021, 25(35): 5644-5649.
[17] 吴克玲, 龚若文, 董旭, 等. 缺氧诱导因子-1信号通路在高眼压模型中的表达[J]. 眼科学报, 2017, 32(3): 125-133.
[18] Tsao CC, Baumann J, Huang SF, et al. Pericyte hypoxia-inducible factor-1 (HIF-1) drives blood-brain barrier disruption and impacts acute ischemic stroke outcome[J]. Angiogenesis, 2021, 24(4): 823-842.
Outlines

/

〈 〉